Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients V Gopalakrishnan, CN Spencer, L Nezi, A Reuben, MC Andrews, ... Science 359 (6371), 97-103, 2018 | 4380 | 2018 |
Identification of bacteria-derived HLA-bound peptides in melanoma S Kalaora, A Nagler, D Nejman, M Alon, C Barbolin, E Barnea, ... Nature 592 (7852), 138-143, 2021 | 305 | 2021 |
Complete genome sequence of Enterococcus faecium strain TX16 and comparative genomic analysis of Enterococcus faecium genomes X Qin, JR Galloway-Peña, J Sillanpaa, JH Roh, SR Nallapareddy, ... BMC microbiology 12, 1-20, 2012 | 190 | 2012 |
Genomic and SNP analyses demonstrate a distant separation of the hospital and community-associated clades of Enterococcus faecium J Galloway-Peña, JH Roh, M Latorre, X Qin, BE Murray PloS one 7 (1), e30187, 2012 | 179 | 2012 |
The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia JR Galloway‐Peña, DP Smith, P Sahasrabhojane, NJ Ajami, ... Cancer 122 (14), 2186-2196, 2016 | 169 | 2016 |
Tools for analysis of the microbiome J Galloway-Peña, B Hanson Digestive diseases and sciences 65, 674-685, 2020 | 166 | 2020 |
Molecular Epidemiology of Vancomycin-Resistant Enterococcus faecium: a Prospective, Multicenter Study in South American Hospitals D Panesso, J Reyes, S Rincón, L Díaz, J Galloway-Pena, J Zurita, ... Journal of clinical microbiology 48 (5), 1562-1569, 2010 | 149 | 2010 |
Analysis of Clonality and Antibiotic Resistance among Early Clinical Isolates of Enterococcus faecium in the United States JR Galloway-Peña, SR Nallapareddy, CA Arias, GM Eliopoulos, ... The Journal of infectious diseases 200 (10), 1566-1573, 2009 | 131 | 2009 |
Characterization of oral and gut microbiome temporal variability in hospitalized cancer patients JR Galloway-Peña, DP Smith, P Sahasrabhojane, WD Wadsworth, ... Genome medicine 9, 1-14, 2017 | 108 | 2017 |
An integrative Bayesian Dirichlet-multinomial regression model for the analysis of taxonomic abundances in microbiome data WD Wadsworth, R Argiento, M Guindani, J Galloway-Pena, SA Shelburne, ... BMC bioinformatics 18, 1-12, 2017 | 101 | 2017 |
Sequence type 1 group B Streptococcus, an emerging cause of invasive disease in adults, evolves by small genetic changes AR Flores, J Galloway-Peña, P Sahasrabhojane, M Saldaña, H Yao, X Su, ... Proceedings of the National Academy of Sciences 112 (20), 6431-6436, 2015 | 99 | 2015 |
Analysis of PBP5 of early US isolates of Enterococcus faecium: sequence variation alone does not explain increasing ampicillin resistance over time JR Galloway-Pena, LB Rice, BE Murray Antimicrobial agents and chemotherapy 55 (7), 3272-3277, 2011 | 96 | 2011 |
Gut microbiome signatures are predictive of infectious risk following induction therapy for acute myeloid leukemia JR Galloway-Peña, Y Shi, CB Peterson, P Sahasrabhojane, ... Clinical Infectious Diseases 71 (1), 63-71, 2020 | 91 | 2020 |
Mucus-degrading Bacteroides link carbapenems to aggravated graft-versus-host disease E Hayase, T Hayase, MA Jamal, T Miyama, CC Chang, MR Ortega, ... Cell 185 (20), 3705-3719. e14, 2022 | 67 | 2022 |
Impact of the microbiota on bacterial infections during cancer treatment J Galloway-Peña, C Brumlow, S Shelburne Trends in microbiology 25 (12), 992-1004, 2017 | 67 | 2017 |
Implementation of a pan-genomic approach to investigate holobiont-infecting microbe interaction: a case report of a leukemic patient with invasive mucormycosis SA Shelburne, NJ Ajami, MC Chibucos, HC Beird, J Tarrand, ... PLoS One 10 (11), e0139851, 2015 | 60 | 2015 |
IS26-mediated amplification of blaOXA-1 and blaCTX-M-15 with concurrent outer membrane porin disruption associated with de novo carbapenem resistance … WC Shropshire, SL Aitken, R Pifer, J Kim, MM Bhatti, X Li, A Kalia, ... Journal of Antimicrobial Chemotherapy 76 (2), 385-395, 2021 | 43 | 2021 |
Fecal microbiome, metabolites, and stem cell transplant outcomes: a single-center pilot study JR Galloway-Peña, CB Peterson, F Malik, PV Sahasrabhojane, DP Shah, ... Open forum infectious diseases 6 (5), ofz173, 2019 | 41 | 2019 |
Diversity of the fsr-gelE Region of the Enterococcus faecalis Genome but Conservation in Strains with Partial Deletions of the fsr Operon JR Galloway-Pena, A Bourgogne, X Qin, BE Murray Applied and environmental microbiology 77 (2), 442-451, 2011 | 38 | 2011 |
The gut mycobiome: the overlooked constituent of clinical outcomes and treatment complications in patients with cancer and other immunosuppressive conditions JR Galloway-Peña, DP Kontoyiannis PLoS pathogens 16 (4), e1008353, 2020 | 37 | 2020 |